KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Income from Continuing Operations (2016 - 2025)

Opko Health (OPK) has disclosed Income from Continuing Operations for 16 consecutive years, with 46239000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 260.66% year-over-year to 46239000.0, compared with a TTM value of 240650000.0 through Dec 2025, down 525.67%, and an annual FY2025 reading of 240650000.0, down 525.68% over the prior year.
  • Income from Continuing Operations was 46239000.0 for Q4 2025 at Opko Health, down from 21634000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 31121000.0 in Q1 2021 and bottomed at 159612000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 44983200.0, with a median of 50811500.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations soared 152.75% in 2021, then tumbled 1340.62% in 2025.
  • Year by year, Income from Continuing Operations stood at 73309000.0 in 2021, then plummeted by 117.72% to 159612000.0 in 2022, then soared by 58.44% to 66329000.0 in 2023, then skyrocketed by 143.39% to 28781000.0 in 2024, then plummeted by 260.66% to 46239000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for OPK at 46239000.0 in Q4 2025, 21634000.0 in Q3 2025, and 148441000.0 in Q2 2025.